Bull vs. Bear Debate: Is Biotech Is in a Bubble?
March 30, 2015 8:00am by Barry Ritholtz
This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment. The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client. References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. The Compound Media, Inc., an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. Investments in securities involve the risk of loss. For additional advertisement disclaimers see here: https://www.ritholtzwealth.com/advertising-disclaimers Please see disclosures here: https://ritholtzwealth.com/blog-disclosures/
What's been said:
Discussions found on the web:Posted Under
Previous Post
10 Monday AM Reads
Beware of double bubble trouble.
Theoretically the major ethical companies doing the buying should be very informed purchasers…
That’s not so much of an argument as an automatic gainsaying of what the other person says. I came here for an argument. (“There’s a window! There is not a window!”)
I have kind of mixed feelings about this–I live in the biotech ground zero (we can watch new lab buildings going up from our house), so all the money has definitely had an impact on the neighborhood. If the money went away, that would be bad. Investors can be fickle, and may have placed their bets on the wrong horses. As happened in the ’90s–the internet was indeed transformative and changed the way we live and do business, but much of the investor money was still unwisely spent. The fact that there will likely always be a need for the products of biotech companies doesn’t mean that can’t happen again.
So what is going to happen? Will Biotech grow to the sky???? I’ll tell you in five years what you should have done.
Me, I took all the profits from biotech and health care off the table about a week ago.